Resources
Search all resources on this page or select a tab to see publications, videos, audio, collections of related resources and more.
Life Saving Drugs Program – Asfotase alfa (Strensiq®) outcome statement – 13 May 2022
This document states the outcome of Alexion Pharmaceuticals Australasia's application to include asfotase alfa on the Life Saving Drugs Program.
Life Saving Drugs Program – Information for patients
Health professionals can print this fact sheet and give it to patients who are starting treatment under the Life Saving Drugs Program.
Life Saving Drugs Program resources – Perinatal- and infantile-onset hypophosphatasia (HPP)
A collection of resources for health professionals to help people with perinatal- and infantile-onset hypophosphatasia (HPP) access asfotase alfa (Strensiq®) under the Life Saving Drugs Program.
Life Saving Drugs Program – Perinatal- and infantile-onset hypophosphatasia (HPP) – Patient test results spreadsheet
Specialists use this spreadsheet to report their patient's test results when reapplying for treatment under the Life Saving Drugs Program.
Life Saving Drugs Program – Perinatal- and infantile-onset hypophosphatasia (HPP) – Reapplication
Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for HPP.
Life Saving Drugs Program – Perinatal- and infantile-onset hypophosphatasia (HPP) – Initial application
Treating physicians use this application form to apply for a patient to access LSDP medication for HPP for the first time, or after a break.
Life Saving Drugs Program – Perinatal- and infantile-onset hypophosphatasia (HPP) – Guidelines
These guidelines contain the general, initial and ongoing eligibility requirements to access asfotase alfa (Strensiq®) for perinatal- and infantile-onset hypophosphatasia under the Life Saving Drugs Program.
Health Funding Facts
Health Funding Facts shows how much aged care, hospital, Medicare and medicines funding your local area receives from the Australian Government.
Life Saving Drugs Program (LSDP) – Medicines reviews recommendations
This document outlines 51 recommendations from the Life Saving Drugs (LSDP) expert panel review.
Care for your health – Your guide to electronic prescribing (other languages)
This language set contains translations of a fact sheet outlining how to access medicines through electronic prescriptions.
Budget 2022–23: Investing in effective treatments
A Budget 2022–23 fact sheet.
Part of a collection: Budget 2022–23: COVID-19Budget 2022–23: Guaranteeing Medicare and access to medicines
A collection of fact sheets from the 2022–23 Budget.
Care for your health – Your guide to electronic prescribing
This fact sheet outlines accessing medicines through electronic prescriptions.
Part of a collection: Care for your health – Campaign materialsCOVID-19 National Health Plan – prescriptions via telehealth – a guide for pharmacists
Electronic prescribing has been fast-tracked as part of the National Health Plan for coronavirus (COVID-19). This guide for pharmacists outlines the temporary arrangements available now that will help patients receive medicines via telehealth services.
COVID-19 National Health Plan – prescriptions via telehealth – a guide for prescribers
Electronic prescribing has been fast-tracked as part of the National Health Plan for coronavirus (COVID-19). This guide for prescribers outlines the temporary arrangements available now that will help patients receive medicines via telehealth services.
Budget 2022–23: New medicines added to the Pharmaceutical Benefits Scheme
A Budget 2022–23 fact sheet.
Part of a collection: Budget 2022–23: Guaranteeing Medicare and access to medicinesBudget 2022–23: Pharmaceutical Benefits Scheme Safety Net
A Budget 2022–23 fact sheet.
Part of a collection: Budget 2022–23: Guaranteeing Medicare and access to medicinesCOVID-19 oral treatments – Information for residents and their families in residential aged care facilities
This fact sheet outlines how and when oral treatments for COVID-19 will be administered in residential aged care facilities.
Life Saving Drugs Program resources – Paroxysmal nocturnal haemoglobinuria
A collection of resources for health professionals to help people with paroxysmal nocturnal haemoglobinuria access eculizumab (Soliris®) under the Life Saving Drugs Program.
Fact sheet for patients – New arrangements for eculizumab (Soliris®) for treatment of paroxysmal nocturnal haemoglobinuria
This fact sheet explains changes to the way we provide access to eculizumab (Soliris®) for patients with paroxysmal nocturnal haemoglobinuria from 1 March 2022.
Part of a collection: Life Saving Drugs Program resources – Paroxysmal nocturnal haemoglobinuriaFact sheet for prescribers – New arrangements for eculizumab (Soliris®)
This fact sheet for prescribers explains changes to the way we provide access to eculizumab (Soliris®) for patients with paroxysmal nocturnal haemoglobinuria from 1 March 2022. It outlines what prescribers need to do to transition their patients to the new arrangements.
Part of a collection: Life Saving Drugs Program resources – Paroxysmal nocturnal haemoglobinuriaCoronavirus (COVID-19) – Use of Paxlovid (nirmatrelvir + ritonavir) in residential aged care
This fact sheet outlines the key considerations of introducing Paxlovid® (nirmatrelvir + ritonavir) into residential aged care clinical practices.
Electronic Prescriptions Data Usage Policy
This policy describes how personal information and related data contained in electronic prescriptions is collected, used and disclosed.
Part of a collection: Electronic prescribing resourcesElectronic Prescriptions Privacy Policy
This policy outlines the privacy responsibilities of non-government organisations involved in the electronic prescribing process.
Part of a collection: Electronic prescribing resourcesElectronic Prescriptions Security and Access Policy
The Electronic Prescriptions Security and Access Policy describes how health care provider organisations must manage the security and integrity of their software, to make sure they dispense electronic prescriptions securely.
Part of a collection: Electronic prescribing resources